Does Sevelamer Interact with Mycophenilic Acid?
CDI records a major classification for Sevelamer and Mycophenilic Acid. The stored summary is: May decrease mycophenolic acid plasma concentrations; concomitant use is not recommended. The mechanism involves phosphate binder interference with drug absorption. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Mycophenilic Acid Class
- Antimetabolite Immunosuppressant
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Phosphate binder interference with drug absorption
What To Tell Your Doctor or Pharmacist
If you are taking Sevelamer and your doctor is considering prescribing Mycophenilic Acid (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider